Bilal Sheikh

Dr. Bilal Sheikh serves as Group Leader of the Junior Research Group "Vascular Epigenetics" at the Helmholtz Institute for Metabolic, Obesity and Vascular Research (Helmholtz Munich), formally affiliated with the University of Leipzig's Faculty of Medicine. His research investigates how metabolic environments interact with the epigenome to influence vascular dysfunction and chronic disease pathogenesis.

His academic training includes a Bachelor of Biomedical Science (with Honors) from the University of Melbourne (2002-2006) and a PhD from the Walter and Eliza Hall Institute, Melbourne (2008-2012).

Sheikh's research focuses on epigenetic regulation in vascular contexts, particularly how environmental factors alter gene expression through metabolic-epigenome crosstalk. His work targets mechanisms underlying atherosclerosis, cardiac failure, and neurodegeneration using single-cell genomic approaches to map transcriptional networks in vascular tissues.

His publication record reveals consistent emphasis on epigenetic drivers of vascular pathology, with recurring themes in neural-vascular metabolic coupling, KAT enzyme functionality, and stem cell regulation. These studies bridge molecular epigenetics with clinical vascular outcomes across neuroscience, oncology, and developmental biology disciplines.

Major recognitions include:

• Alexander von Humboldt International Fellowship (2015)
• Theo Murphy High Flyer's Think Tank, Australian Academy of Sciences (2013)
• Genetic Services Research Prize, University of Queensland (2012)
• Australian Stem Cell Centre Postgraduate Award (2008)
• Dora Lush Fellowship
• Dean's Honor's list recipient, University of Melbourne
• Speed-Colemann Prize

As principal investigator, Sheikh directs grant-funded research programs and mentors junior scientists in epigenetic methodology development, with projects supported by Helmholtz Association infrastructure and international fellowships.

The Vascular Epigenetics laboratory integrates metabolomics, single-cell sequencing, and vascular phenotyping to decode environment-genome interactions, maintaining active collaborations with European Vascular Biology Organization and Leipzig University's medical research ecosystem.